Named Board Chairman At Shaman Pharmaceuticals Author: Franklin Hoke

After an abrupt departure in July from his posts as president, chief executive officer, and director of Genentech Inc., G. Kirk Raab, 59, was elected chairman of the smaller Shaman Pharmaceuticals Inc. last month. Both biotechnology companies are based in South San Francisco, Calif.

G. Kirk Raab BACK IN THE SADDLE: As board chairman, G. Kirk Raab will advise Shaman Pharmaceuticals' president and CEO, Lisa Conte. Shaman's approach to finding candidate drugs is to identify plant-based medicines being used in traditional and tribal cultures; these substances are then investigated further in the laboratory. Raab, whose primarily advisory role at Shaman will support company president and CEO Lisa Conte, says that he is also talking to a number of other companies about establishing similar advisory relationships with them.

According to a Genentech statement, Raab was dismissed by Genentech's board of directors after disclosure that...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?